Global Neurodegenerative Disease Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Neurodegenerative Disease market size was valued at USD 7206 million in 2023 and is forecast to a readjusted size of USD 8853 million by 2030 with a CAGR of 3.0% during review period.
Neurodegenerative diseases are a group of disorders characterized by the progressive degeneration of the structure and function of the nervous system, leading to cognitive and motor impairments. Examples include Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS).
The market for neurodegenerative disease treatments and management is driven by the increasing prevalence of these diseases, particularly with an aging population. The market's growth is also influenced by the demand for disease-modifying therapies and symptom management options to improve the quality of life for patients.
The Global Info Research report includes an overview of the development of the Neurodegenerative Disease industry chain, the market status of Parkinson’s Disease (NMDA, SSRIs), Huntington Disease (NMDA, SSRIs), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Neurodegenerative Disease.
Regionally, the report analyzes the Neurodegenerative Disease markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Neurodegenerative Disease market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Neurodegenerative Disease market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Neurodegenerative Disease industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., NMDA, SSRIs).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Neurodegenerative Disease market.
Regional Analysis: The report involves examining the Neurodegenerative Disease market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Neurodegenerative Disease market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Neurodegenerative Disease:
Company Analysis: Report covers individual Neurodegenerative Disease players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Neurodegenerative Disease This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Parkinson’s Disease, Huntington Disease).
Technology Analysis: Report covers specific technologies relevant to Neurodegenerative Disease. It assesses the current state, advancements, and potential future developments in Neurodegenerative Disease areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Neurodegenerative Disease market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Neurodegenerative Disease market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Neurodegenerative Disease product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Neurodegenerative Disease, with revenue, gross margin and global market share of Neurodegenerative Disease from 2019 to 2024.
Chapter 3, the Neurodegenerative Disease competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Neurodegenerative Disease market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Neurodegenerative Disease.
Chapter 13, to describe Neurodegenerative Disease research findings and conclusion.
Neurodegenerative diseases are a group of disorders characterized by the progressive degeneration of the structure and function of the nervous system, leading to cognitive and motor impairments. Examples include Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS).
The market for neurodegenerative disease treatments and management is driven by the increasing prevalence of these diseases, particularly with an aging population. The market's growth is also influenced by the demand for disease-modifying therapies and symptom management options to improve the quality of life for patients.
The Global Info Research report includes an overview of the development of the Neurodegenerative Disease industry chain, the market status of Parkinson’s Disease (NMDA, SSRIs), Huntington Disease (NMDA, SSRIs), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Neurodegenerative Disease.
Regionally, the report analyzes the Neurodegenerative Disease markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Neurodegenerative Disease market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Neurodegenerative Disease market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Neurodegenerative Disease industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., NMDA, SSRIs).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Neurodegenerative Disease market.
Regional Analysis: The report involves examining the Neurodegenerative Disease market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Neurodegenerative Disease market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Neurodegenerative Disease:
Company Analysis: Report covers individual Neurodegenerative Disease players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Neurodegenerative Disease This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Parkinson’s Disease, Huntington Disease).
Technology Analysis: Report covers specific technologies relevant to Neurodegenerative Disease. It assesses the current state, advancements, and potential future developments in Neurodegenerative Disease areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Neurodegenerative Disease market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Neurodegenerative Disease market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- NMDA
- SSRIs
- Dopamine Inhibitors
- Parkinson’s Disease
- Huntington Disease
- Amyotrophic Lateral Sclerosis
- Alzheimer’s Disease
- Novartis
- Pfizer
- Merck Serono
- Biogen Idec
- TEVA
- UCB
- Boehringer Ingelheim
- Sanofi
- GlaxoSmithKline
- Livzon Pharmaceutical
- Haisco Pharmaceutical
- Jingxin Pharmaceutical
- Dongcheng Biochemicals
- Hisun Pharmaceutical
- Luye Pharma
- Ark Pharmaceutical
- Kanghong Pharmaceutical
- Huahai Pharmaceutical
- BORA PHARMACEUTICALS
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Neurodegenerative Disease product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Neurodegenerative Disease, with revenue, gross margin and global market share of Neurodegenerative Disease from 2019 to 2024.
Chapter 3, the Neurodegenerative Disease competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Neurodegenerative Disease market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Neurodegenerative Disease.
Chapter 13, to describe Neurodegenerative Disease research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Neurodegenerative Disease
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Neurodegenerative Disease by Type
1.3.1 Overview: Global Neurodegenerative Disease Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Neurodegenerative Disease Consumption Value Market Share by Type in 2023
1.3.3 NMDA
1.3.4 SSRIs
1.3.5 Dopamine Inhibitors
1.4 Global Neurodegenerative Disease Market by Application
1.4.1 Overview: Global Neurodegenerative Disease Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Parkinson’s Disease
1.4.3 Huntington Disease
1.4.4 Amyotrophic Lateral Sclerosis
1.4.5 Alzheimer’s Disease
1.5 Global Neurodegenerative Disease Market Size & Forecast
1.6 Global Neurodegenerative Disease Market Size and Forecast by Region
1.6.1 Global Neurodegenerative Disease Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Neurodegenerative Disease Market Size by Region, (2019-2030)
1.6.3 North America Neurodegenerative Disease Market Size and Prospect (2019-2030)
1.6.4 Europe Neurodegenerative Disease Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Neurodegenerative Disease Market Size and Prospect (2019-2030)
1.6.6 South America Neurodegenerative Disease Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Neurodegenerative Disease Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Neurodegenerative Disease Product and Solutions
2.1.4 Novartis Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Novartis Recent Developments and Future Plans
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Neurodegenerative Disease Product and Solutions
2.2.4 Pfizer Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Pfizer Recent Developments and Future Plans
2.3 Merck Serono
2.3.1 Merck Serono Details
2.3.2 Merck Serono Major Business
2.3.3 Merck Serono Neurodegenerative Disease Product and Solutions
2.3.4 Merck Serono Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Merck Serono Recent Developments and Future Plans
2.4 Biogen Idec
2.4.1 Biogen Idec Details
2.4.2 Biogen Idec Major Business
2.4.3 Biogen Idec Neurodegenerative Disease Product and Solutions
2.4.4 Biogen Idec Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Biogen Idec Recent Developments and Future Plans
2.5 TEVA
2.5.1 TEVA Details
2.5.2 TEVA Major Business
2.5.3 TEVA Neurodegenerative Disease Product and Solutions
2.5.4 TEVA Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 TEVA Recent Developments and Future Plans
2.6 UCB
2.6.1 UCB Details
2.6.2 UCB Major Business
2.6.3 UCB Neurodegenerative Disease Product and Solutions
2.6.4 UCB Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 UCB Recent Developments and Future Plans
2.7 Boehringer Ingelheim
2.7.1 Boehringer Ingelheim Details
2.7.2 Boehringer Ingelheim Major Business
2.7.3 Boehringer Ingelheim Neurodegenerative Disease Product and Solutions
2.7.4 Boehringer Ingelheim Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Boehringer Ingelheim Recent Developments and Future Plans
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Neurodegenerative Disease Product and Solutions
2.8.4 Sanofi Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Sanofi Recent Developments and Future Plans
2.9 GlaxoSmithKline
2.9.1 GlaxoSmithKline Details
2.9.2 GlaxoSmithKline Major Business
2.9.3 GlaxoSmithKline Neurodegenerative Disease Product and Solutions
2.9.4 GlaxoSmithKline Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 GlaxoSmithKline Recent Developments and Future Plans
2.10 Livzon Pharmaceutical
2.10.1 Livzon Pharmaceutical Details
2.10.2 Livzon Pharmaceutical Major Business
2.10.3 Livzon Pharmaceutical Neurodegenerative Disease Product and Solutions
2.10.4 Livzon Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Livzon Pharmaceutical Recent Developments and Future Plans
2.11 Haisco Pharmaceutical
2.11.1 Haisco Pharmaceutical Details
2.11.2 Haisco Pharmaceutical Major Business
2.11.3 Haisco Pharmaceutical Neurodegenerative Disease Product and Solutions
2.11.4 Haisco Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Haisco Pharmaceutical Recent Developments and Future Plans
2.12 Jingxin Pharmaceutical
2.12.1 Jingxin Pharmaceutical Details
2.12.2 Jingxin Pharmaceutical Major Business
2.12.3 Jingxin Pharmaceutical Neurodegenerative Disease Product and Solutions
2.12.4 Jingxin Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Jingxin Pharmaceutical Recent Developments and Future Plans
2.13 Dongcheng Biochemicals
2.13.1 Dongcheng Biochemicals Details
2.13.2 Dongcheng Biochemicals Major Business
2.13.3 Dongcheng Biochemicals Neurodegenerative Disease Product and Solutions
2.13.4 Dongcheng Biochemicals Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Dongcheng Biochemicals Recent Developments and Future Plans
2.14 Hisun Pharmaceutical
2.14.1 Hisun Pharmaceutical Details
2.14.2 Hisun Pharmaceutical Major Business
2.14.3 Hisun Pharmaceutical Neurodegenerative Disease Product and Solutions
2.14.4 Hisun Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Hisun Pharmaceutical Recent Developments and Future Plans
2.15 Luye Pharma
2.15.1 Luye Pharma Details
2.15.2 Luye Pharma Major Business
2.15.3 Luye Pharma Neurodegenerative Disease Product and Solutions
2.15.4 Luye Pharma Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Luye Pharma Recent Developments and Future Plans
2.16 Ark Pharmaceutical
2.16.1 Ark Pharmaceutical Details
2.16.2 Ark Pharmaceutical Major Business
2.16.3 Ark Pharmaceutical Neurodegenerative Disease Product and Solutions
2.16.4 Ark Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Ark Pharmaceutical Recent Developments and Future Plans
2.17 Kanghong Pharmaceutical
2.17.1 Kanghong Pharmaceutical Details
2.17.2 Kanghong Pharmaceutical Major Business
2.17.3 Kanghong Pharmaceutical Neurodegenerative Disease Product and Solutions
2.17.4 Kanghong Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Kanghong Pharmaceutical Recent Developments and Future Plans
2.18 Huahai Pharmaceutical
2.18.1 Huahai Pharmaceutical Details
2.18.2 Huahai Pharmaceutical Major Business
2.18.3 Huahai Pharmaceutical Neurodegenerative Disease Product and Solutions
2.18.4 Huahai Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Huahai Pharmaceutical Recent Developments and Future Plans
2.19 BORA PHARMACEUTICALS
2.19.1 BORA PHARMACEUTICALS Details
2.19.2 BORA PHARMACEUTICALS Major Business
2.19.3 BORA PHARMACEUTICALS Neurodegenerative Disease Product and Solutions
2.19.4 BORA PHARMACEUTICALS Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 BORA PHARMACEUTICALS Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Neurodegenerative Disease Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Neurodegenerative Disease by Company Revenue
3.2.2 Top 3 Neurodegenerative Disease Players Market Share in 2023
3.2.3 Top 6 Neurodegenerative Disease Players Market Share in 2023
3.3 Neurodegenerative Disease Market: Overall Company Footprint Analysis
3.3.1 Neurodegenerative Disease Market: Region Footprint
3.3.2 Neurodegenerative Disease Market: Company Product Type Footprint
3.3.3 Neurodegenerative Disease Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Neurodegenerative Disease Consumption Value and Market Share by Type (2019-2024)
4.2 Global Neurodegenerative Disease Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Neurodegenerative Disease Consumption Value Market Share by Application (2019-2024)
5.2 Global Neurodegenerative Disease Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Neurodegenerative Disease Consumption Value by Type (2019-2030)
6.2 North America Neurodegenerative Disease Consumption Value by Application (2019-2030)
6.3 North America Neurodegenerative Disease Market Size by Country
6.3.1 North America Neurodegenerative Disease Consumption Value by Country (2019-2030)
6.3.2 United States Neurodegenerative Disease Market Size and Forecast (2019-2030)
6.3.3 Canada Neurodegenerative Disease Market Size and Forecast (2019-2030)
6.3.4 Mexico Neurodegenerative Disease Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Neurodegenerative Disease Consumption Value by Type (2019-2030)
7.2 Europe Neurodegenerative Disease Consumption Value by Application (2019-2030)
7.3 Europe Neurodegenerative Disease Market Size by Country
7.3.1 Europe Neurodegenerative Disease Consumption Value by Country (2019-2030)
7.3.2 Germany Neurodegenerative Disease Market Size and Forecast (2019-2030)
7.3.3 France Neurodegenerative Disease Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Neurodegenerative Disease Market Size and Forecast (2019-2030)
7.3.5 Russia Neurodegenerative Disease Market Size and Forecast (2019-2030)
7.3.6 Italy Neurodegenerative Disease Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Neurodegenerative Disease Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Neurodegenerative Disease Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Neurodegenerative Disease Market Size by Region
8.3.1 Asia-Pacific Neurodegenerative Disease Consumption Value by Region (2019-2030)
8.3.2 China Neurodegenerative Disease Market Size and Forecast (2019-2030)
8.3.3 Japan Neurodegenerative Disease Market Size and Forecast (2019-2030)
8.3.4 South Korea Neurodegenerative Disease Market Size and Forecast (2019-2030)
8.3.5 India Neurodegenerative Disease Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Neurodegenerative Disease Market Size and Forecast (2019-2030)
8.3.7 Australia Neurodegenerative Disease Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Neurodegenerative Disease Consumption Value by Type (2019-2030)
9.2 South America Neurodegenerative Disease Consumption Value by Application (2019-2030)
9.3 South America Neurodegenerative Disease Market Size by Country
9.3.1 South America Neurodegenerative Disease Consumption Value by Country (2019-2030)
9.3.2 Brazil Neurodegenerative Disease Market Size and Forecast (2019-2030)
9.3.3 Argentina Neurodegenerative Disease Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Neurodegenerative Disease Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Neurodegenerative Disease Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Neurodegenerative Disease Market Size by Country
10.3.1 Middle East & Africa Neurodegenerative Disease Consumption Value by Country (2019-2030)
10.3.2 Turkey Neurodegenerative Disease Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Neurodegenerative Disease Market Size and Forecast (2019-2030)
10.3.4 UAE Neurodegenerative Disease Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Neurodegenerative Disease Market Drivers
11.2 Neurodegenerative Disease Market Restraints
11.3 Neurodegenerative Disease Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Neurodegenerative Disease Industry Chain
12.2 Neurodegenerative Disease Upstream Analysis
12.3 Neurodegenerative Disease Midstream Analysis
12.4 Neurodegenerative Disease Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Neurodegenerative Disease
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Neurodegenerative Disease by Type
1.3.1 Overview: Global Neurodegenerative Disease Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Neurodegenerative Disease Consumption Value Market Share by Type in 2023
1.3.3 NMDA
1.3.4 SSRIs
1.3.5 Dopamine Inhibitors
1.4 Global Neurodegenerative Disease Market by Application
1.4.1 Overview: Global Neurodegenerative Disease Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Parkinson’s Disease
1.4.3 Huntington Disease
1.4.4 Amyotrophic Lateral Sclerosis
1.4.5 Alzheimer’s Disease
1.5 Global Neurodegenerative Disease Market Size & Forecast
1.6 Global Neurodegenerative Disease Market Size and Forecast by Region
1.6.1 Global Neurodegenerative Disease Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Neurodegenerative Disease Market Size by Region, (2019-2030)
1.6.3 North America Neurodegenerative Disease Market Size and Prospect (2019-2030)
1.6.4 Europe Neurodegenerative Disease Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Neurodegenerative Disease Market Size and Prospect (2019-2030)
1.6.6 South America Neurodegenerative Disease Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Neurodegenerative Disease Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Neurodegenerative Disease Product and Solutions
2.1.4 Novartis Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Novartis Recent Developments and Future Plans
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Neurodegenerative Disease Product and Solutions
2.2.4 Pfizer Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Pfizer Recent Developments and Future Plans
2.3 Merck Serono
2.3.1 Merck Serono Details
2.3.2 Merck Serono Major Business
2.3.3 Merck Serono Neurodegenerative Disease Product and Solutions
2.3.4 Merck Serono Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Merck Serono Recent Developments and Future Plans
2.4 Biogen Idec
2.4.1 Biogen Idec Details
2.4.2 Biogen Idec Major Business
2.4.3 Biogen Idec Neurodegenerative Disease Product and Solutions
2.4.4 Biogen Idec Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Biogen Idec Recent Developments and Future Plans
2.5 TEVA
2.5.1 TEVA Details
2.5.2 TEVA Major Business
2.5.3 TEVA Neurodegenerative Disease Product and Solutions
2.5.4 TEVA Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 TEVA Recent Developments and Future Plans
2.6 UCB
2.6.1 UCB Details
2.6.2 UCB Major Business
2.6.3 UCB Neurodegenerative Disease Product and Solutions
2.6.4 UCB Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 UCB Recent Developments and Future Plans
2.7 Boehringer Ingelheim
2.7.1 Boehringer Ingelheim Details
2.7.2 Boehringer Ingelheim Major Business
2.7.3 Boehringer Ingelheim Neurodegenerative Disease Product and Solutions
2.7.4 Boehringer Ingelheim Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Boehringer Ingelheim Recent Developments and Future Plans
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Neurodegenerative Disease Product and Solutions
2.8.4 Sanofi Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Sanofi Recent Developments and Future Plans
2.9 GlaxoSmithKline
2.9.1 GlaxoSmithKline Details
2.9.2 GlaxoSmithKline Major Business
2.9.3 GlaxoSmithKline Neurodegenerative Disease Product and Solutions
2.9.4 GlaxoSmithKline Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 GlaxoSmithKline Recent Developments and Future Plans
2.10 Livzon Pharmaceutical
2.10.1 Livzon Pharmaceutical Details
2.10.2 Livzon Pharmaceutical Major Business
2.10.3 Livzon Pharmaceutical Neurodegenerative Disease Product and Solutions
2.10.4 Livzon Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Livzon Pharmaceutical Recent Developments and Future Plans
2.11 Haisco Pharmaceutical
2.11.1 Haisco Pharmaceutical Details
2.11.2 Haisco Pharmaceutical Major Business
2.11.3 Haisco Pharmaceutical Neurodegenerative Disease Product and Solutions
2.11.4 Haisco Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Haisco Pharmaceutical Recent Developments and Future Plans
2.12 Jingxin Pharmaceutical
2.12.1 Jingxin Pharmaceutical Details
2.12.2 Jingxin Pharmaceutical Major Business
2.12.3 Jingxin Pharmaceutical Neurodegenerative Disease Product and Solutions
2.12.4 Jingxin Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Jingxin Pharmaceutical Recent Developments and Future Plans
2.13 Dongcheng Biochemicals
2.13.1 Dongcheng Biochemicals Details
2.13.2 Dongcheng Biochemicals Major Business
2.13.3 Dongcheng Biochemicals Neurodegenerative Disease Product and Solutions
2.13.4 Dongcheng Biochemicals Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Dongcheng Biochemicals Recent Developments and Future Plans
2.14 Hisun Pharmaceutical
2.14.1 Hisun Pharmaceutical Details
2.14.2 Hisun Pharmaceutical Major Business
2.14.3 Hisun Pharmaceutical Neurodegenerative Disease Product and Solutions
2.14.4 Hisun Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Hisun Pharmaceutical Recent Developments and Future Plans
2.15 Luye Pharma
2.15.1 Luye Pharma Details
2.15.2 Luye Pharma Major Business
2.15.3 Luye Pharma Neurodegenerative Disease Product and Solutions
2.15.4 Luye Pharma Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Luye Pharma Recent Developments and Future Plans
2.16 Ark Pharmaceutical
2.16.1 Ark Pharmaceutical Details
2.16.2 Ark Pharmaceutical Major Business
2.16.3 Ark Pharmaceutical Neurodegenerative Disease Product and Solutions
2.16.4 Ark Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Ark Pharmaceutical Recent Developments and Future Plans
2.17 Kanghong Pharmaceutical
2.17.1 Kanghong Pharmaceutical Details
2.17.2 Kanghong Pharmaceutical Major Business
2.17.3 Kanghong Pharmaceutical Neurodegenerative Disease Product and Solutions
2.17.4 Kanghong Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Kanghong Pharmaceutical Recent Developments and Future Plans
2.18 Huahai Pharmaceutical
2.18.1 Huahai Pharmaceutical Details
2.18.2 Huahai Pharmaceutical Major Business
2.18.3 Huahai Pharmaceutical Neurodegenerative Disease Product and Solutions
2.18.4 Huahai Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Huahai Pharmaceutical Recent Developments and Future Plans
2.19 BORA PHARMACEUTICALS
2.19.1 BORA PHARMACEUTICALS Details
2.19.2 BORA PHARMACEUTICALS Major Business
2.19.3 BORA PHARMACEUTICALS Neurodegenerative Disease Product and Solutions
2.19.4 BORA PHARMACEUTICALS Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 BORA PHARMACEUTICALS Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Neurodegenerative Disease Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Neurodegenerative Disease by Company Revenue
3.2.2 Top 3 Neurodegenerative Disease Players Market Share in 2023
3.2.3 Top 6 Neurodegenerative Disease Players Market Share in 2023
3.3 Neurodegenerative Disease Market: Overall Company Footprint Analysis
3.3.1 Neurodegenerative Disease Market: Region Footprint
3.3.2 Neurodegenerative Disease Market: Company Product Type Footprint
3.3.3 Neurodegenerative Disease Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Neurodegenerative Disease Consumption Value and Market Share by Type (2019-2024)
4.2 Global Neurodegenerative Disease Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Neurodegenerative Disease Consumption Value Market Share by Application (2019-2024)
5.2 Global Neurodegenerative Disease Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Neurodegenerative Disease Consumption Value by Type (2019-2030)
6.2 North America Neurodegenerative Disease Consumption Value by Application (2019-2030)
6.3 North America Neurodegenerative Disease Market Size by Country
6.3.1 North America Neurodegenerative Disease Consumption Value by Country (2019-2030)
6.3.2 United States Neurodegenerative Disease Market Size and Forecast (2019-2030)
6.3.3 Canada Neurodegenerative Disease Market Size and Forecast (2019-2030)
6.3.4 Mexico Neurodegenerative Disease Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Neurodegenerative Disease Consumption Value by Type (2019-2030)
7.2 Europe Neurodegenerative Disease Consumption Value by Application (2019-2030)
7.3 Europe Neurodegenerative Disease Market Size by Country
7.3.1 Europe Neurodegenerative Disease Consumption Value by Country (2019-2030)
7.3.2 Germany Neurodegenerative Disease Market Size and Forecast (2019-2030)
7.3.3 France Neurodegenerative Disease Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Neurodegenerative Disease Market Size and Forecast (2019-2030)
7.3.5 Russia Neurodegenerative Disease Market Size and Forecast (2019-2030)
7.3.6 Italy Neurodegenerative Disease Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Neurodegenerative Disease Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Neurodegenerative Disease Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Neurodegenerative Disease Market Size by Region
8.3.1 Asia-Pacific Neurodegenerative Disease Consumption Value by Region (2019-2030)
8.3.2 China Neurodegenerative Disease Market Size and Forecast (2019-2030)
8.3.3 Japan Neurodegenerative Disease Market Size and Forecast (2019-2030)
8.3.4 South Korea Neurodegenerative Disease Market Size and Forecast (2019-2030)
8.3.5 India Neurodegenerative Disease Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Neurodegenerative Disease Market Size and Forecast (2019-2030)
8.3.7 Australia Neurodegenerative Disease Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Neurodegenerative Disease Consumption Value by Type (2019-2030)
9.2 South America Neurodegenerative Disease Consumption Value by Application (2019-2030)
9.3 South America Neurodegenerative Disease Market Size by Country
9.3.1 South America Neurodegenerative Disease Consumption Value by Country (2019-2030)
9.3.2 Brazil Neurodegenerative Disease Market Size and Forecast (2019-2030)
9.3.3 Argentina Neurodegenerative Disease Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Neurodegenerative Disease Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Neurodegenerative Disease Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Neurodegenerative Disease Market Size by Country
10.3.1 Middle East & Africa Neurodegenerative Disease Consumption Value by Country (2019-2030)
10.3.2 Turkey Neurodegenerative Disease Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Neurodegenerative Disease Market Size and Forecast (2019-2030)
10.3.4 UAE Neurodegenerative Disease Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Neurodegenerative Disease Market Drivers
11.2 Neurodegenerative Disease Market Restraints
11.3 Neurodegenerative Disease Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Neurodegenerative Disease Industry Chain
12.2 Neurodegenerative Disease Upstream Analysis
12.3 Neurodegenerative Disease Midstream Analysis
12.4 Neurodegenerative Disease Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Neurodegenerative Disease Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Neurodegenerative Disease Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Neurodegenerative Disease Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Neurodegenerative Disease Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Novartis Company Information, Head Office, and Major Competitors
Table 6. Novartis Major Business
Table 7. Novartis Neurodegenerative Disease Product and Solutions
Table 8. Novartis Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Novartis Recent Developments and Future Plans
Table 10. Pfizer Company Information, Head Office, and Major Competitors
Table 11. Pfizer Major Business
Table 12. Pfizer Neurodegenerative Disease Product and Solutions
Table 13. Pfizer Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Pfizer Recent Developments and Future Plans
Table 15. Merck Serono Company Information, Head Office, and Major Competitors
Table 16. Merck Serono Major Business
Table 17. Merck Serono Neurodegenerative Disease Product and Solutions
Table 18. Merck Serono Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Merck Serono Recent Developments and Future Plans
Table 20. Biogen Idec Company Information, Head Office, and Major Competitors
Table 21. Biogen Idec Major Business
Table 22. Biogen Idec Neurodegenerative Disease Product and Solutions
Table 23. Biogen Idec Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Biogen Idec Recent Developments and Future Plans
Table 25. TEVA Company Information, Head Office, and Major Competitors
Table 26. TEVA Major Business
Table 27. TEVA Neurodegenerative Disease Product and Solutions
Table 28. TEVA Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. TEVA Recent Developments and Future Plans
Table 30. UCB Company Information, Head Office, and Major Competitors
Table 31. UCB Major Business
Table 32. UCB Neurodegenerative Disease Product and Solutions
Table 33. UCB Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. UCB Recent Developments and Future Plans
Table 35. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 36. Boehringer Ingelheim Major Business
Table 37. Boehringer Ingelheim Neurodegenerative Disease Product and Solutions
Table 38. Boehringer Ingelheim Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Boehringer Ingelheim Recent Developments and Future Plans
Table 40. Sanofi Company Information, Head Office, and Major Competitors
Table 41. Sanofi Major Business
Table 42. Sanofi Neurodegenerative Disease Product and Solutions
Table 43. Sanofi Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Sanofi Recent Developments and Future Plans
Table 45. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 46. GlaxoSmithKline Major Business
Table 47. GlaxoSmithKline Neurodegenerative Disease Product and Solutions
Table 48. GlaxoSmithKline Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. GlaxoSmithKline Recent Developments and Future Plans
Table 50. Livzon Pharmaceutical Company Information, Head Office, and Major Competitors
Table 51. Livzon Pharmaceutical Major Business
Table 52. Livzon Pharmaceutical Neurodegenerative Disease Product and Solutions
Table 53. Livzon Pharmaceutical Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Livzon Pharmaceutical Recent Developments and Future Plans
Table 55. Haisco Pharmaceutical Company Information, Head Office, and Major Competitors
Table 56. Haisco Pharmaceutical Major Business
Table 57. Haisco Pharmaceutical Neurodegenerative Disease Product and Solutions
Table 58. Haisco Pharmaceutical Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Haisco Pharmaceutical Recent Developments and Future Plans
Table 60. Jingxin Pharmaceutical Company Information, Head Office, and Major Competitors
Table 61. Jingxin Pharmaceutical Major Business
Table 62. Jingxin Pharmaceutical Neurodegenerative Disease Product and Solutions
Table 63. Jingxin Pharmaceutical Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Jingxin Pharmaceutical Recent Developments and Future Plans
Table 65. Dongcheng Biochemicals Company Information, Head Office, and Major Competitors
Table 66. Dongcheng Biochemicals Major Business
Table 67. Dongcheng Biochemicals Neurodegenerative Disease Product and Solutions
Table 68. Dongcheng Biochemicals Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Dongcheng Biochemicals Recent Developments and Future Plans
Table 70. Hisun Pharmaceutical Company Information, Head Office, and Major Competitors
Table 71. Hisun Pharmaceutical Major Business
Table 72. Hisun Pharmaceutical Neurodegenerative Disease Product and Solutions
Table 73. Hisun Pharmaceutical Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Hisun Pharmaceutical Recent Developments and Future Plans
Table 75. Luye Pharma Company Information, Head Office, and Major Competitors
Table 76. Luye Pharma Major Business
Table 77. Luye Pharma Neurodegenerative Disease Product and Solutions
Table 78. Luye Pharma Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Luye Pharma Recent Developments and Future Plans
Table 80. Ark Pharmaceutical Company Information, Head Office, and Major Competitors
Table 81. Ark Pharmaceutical Major Business
Table 82. Ark Pharmaceutical Neurodegenerative Disease Product and Solutions
Table 83. Ark Pharmaceutical Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Ark Pharmaceutical Recent Developments and Future Plans
Table 85. Kanghong Pharmaceutical Company Information, Head Office, and Major Competitors
Table 86. Kanghong Pharmaceutical Major Business
Table 87. Kanghong Pharmaceutical Neurodegenerative Disease Product and Solutions
Table 88. Kanghong Pharmaceutical Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Kanghong Pharmaceutical Recent Developments and Future Plans
Table 90. Huahai Pharmaceutical Company Information, Head Office, and Major Competitors
Table 91. Huahai Pharmaceutical Major Business
Table 92. Huahai Pharmaceutical Neurodegenerative Disease Product and Solutions
Table 93. Huahai Pharmaceutical Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Huahai Pharmaceutical Recent Developments and Future Plans
Table 95. BORA PHARMACEUTICALS Company Information, Head Office, and Major Competitors
Table 96. BORA PHARMACEUTICALS Major Business
Table 97. BORA PHARMACEUTICALS Neurodegenerative Disease Product and Solutions
Table 98. BORA PHARMACEUTICALS Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. BORA PHARMACEUTICALS Recent Developments and Future Plans
Table 100. Global Neurodegenerative Disease Revenue (USD Million) by Players (2019-2024)
Table 101. Global Neurodegenerative Disease Revenue Share by Players (2019-2024)
Table 102. Breakdown of Neurodegenerative Disease by Company Type (Tier 1, Tier 2, and Tier 3)
Table 103. Market Position of Players in Neurodegenerative Disease, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 104. Head Office of Key Neurodegenerative Disease Players
Table 105. Neurodegenerative Disease Market: Company Product Type Footprint
Table 106. Neurodegenerative Disease Market: Company Product Application Footprint
Table 107. Neurodegenerative Disease New Market Entrants and Barriers to Market Entry
Table 108. Neurodegenerative Disease Mergers, Acquisition, Agreements, and Collaborations
Table 109. Global Neurodegenerative Disease Consumption Value (USD Million) by Type (2019-2024)
Table 110. Global Neurodegenerative Disease Consumption Value Share by Type (2019-2024)
Table 111. Global Neurodegenerative Disease Consumption Value Forecast by Type (2025-2030)
Table 112. Global Neurodegenerative Disease Consumption Value by Application (2019-2024)
Table 113. Global Neurodegenerative Disease Consumption Value Forecast by Application (2025-2030)
Table 114. North America Neurodegenerative Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 115. North America Neurodegenerative Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 116. North America Neurodegenerative Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 117. North America Neurodegenerative Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 118. North America Neurodegenerative Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 119. North America Neurodegenerative Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 120. Europe Neurodegenerative Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 121. Europe Neurodegenerative Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 122. Europe Neurodegenerative Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 123. Europe Neurodegenerative Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 124. Europe Neurodegenerative Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 125. Europe Neurodegenerative Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 126. Asia-Pacific Neurodegenerative Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 127. Asia-Pacific Neurodegenerative Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 128. Asia-Pacific Neurodegenerative Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 129. Asia-Pacific Neurodegenerative Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 130. Asia-Pacific Neurodegenerative Disease Consumption Value by Region (2019-2024) & (USD Million)
Table 131. Asia-Pacific Neurodegenerative Disease Consumption Value by Region (2025-2030) & (USD Million)
Table 132. South America Neurodegenerative Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 133. South America Neurodegenerative Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 134. South America Neurodegenerative Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 135. South America Neurodegenerative Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 136. South America Neurodegenerative Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 137. South America Neurodegenerative Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 138. Middle East & Africa Neurodegenerative Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 139. Middle East & Africa Neurodegenerative Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 140. Middle East & Africa Neurodegenerative Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 141. Middle East & Africa Neurodegenerative Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 142. Middle East & Africa Neurodegenerative Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 143. Middle East & Africa Neurodegenerative Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 144. Neurodegenerative Disease Raw Material
Table 145. Key Suppliers of Neurodegenerative Disease Raw Materials
Table 1. Global Neurodegenerative Disease Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Neurodegenerative Disease Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Neurodegenerative Disease Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Neurodegenerative Disease Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Novartis Company Information, Head Office, and Major Competitors
Table 6. Novartis Major Business
Table 7. Novartis Neurodegenerative Disease Product and Solutions
Table 8. Novartis Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Novartis Recent Developments and Future Plans
Table 10. Pfizer Company Information, Head Office, and Major Competitors
Table 11. Pfizer Major Business
Table 12. Pfizer Neurodegenerative Disease Product and Solutions
Table 13. Pfizer Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Pfizer Recent Developments and Future Plans
Table 15. Merck Serono Company Information, Head Office, and Major Competitors
Table 16. Merck Serono Major Business
Table 17. Merck Serono Neurodegenerative Disease Product and Solutions
Table 18. Merck Serono Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Merck Serono Recent Developments and Future Plans
Table 20. Biogen Idec Company Information, Head Office, and Major Competitors
Table 21. Biogen Idec Major Business
Table 22. Biogen Idec Neurodegenerative Disease Product and Solutions
Table 23. Biogen Idec Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Biogen Idec Recent Developments and Future Plans
Table 25. TEVA Company Information, Head Office, and Major Competitors
Table 26. TEVA Major Business
Table 27. TEVA Neurodegenerative Disease Product and Solutions
Table 28. TEVA Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. TEVA Recent Developments and Future Plans
Table 30. UCB Company Information, Head Office, and Major Competitors
Table 31. UCB Major Business
Table 32. UCB Neurodegenerative Disease Product and Solutions
Table 33. UCB Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. UCB Recent Developments and Future Plans
Table 35. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 36. Boehringer Ingelheim Major Business
Table 37. Boehringer Ingelheim Neurodegenerative Disease Product and Solutions
Table 38. Boehringer Ingelheim Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Boehringer Ingelheim Recent Developments and Future Plans
Table 40. Sanofi Company Information, Head Office, and Major Competitors
Table 41. Sanofi Major Business
Table 42. Sanofi Neurodegenerative Disease Product and Solutions
Table 43. Sanofi Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Sanofi Recent Developments and Future Plans
Table 45. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 46. GlaxoSmithKline Major Business
Table 47. GlaxoSmithKline Neurodegenerative Disease Product and Solutions
Table 48. GlaxoSmithKline Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. GlaxoSmithKline Recent Developments and Future Plans
Table 50. Livzon Pharmaceutical Company Information, Head Office, and Major Competitors
Table 51. Livzon Pharmaceutical Major Business
Table 52. Livzon Pharmaceutical Neurodegenerative Disease Product and Solutions
Table 53. Livzon Pharmaceutical Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Livzon Pharmaceutical Recent Developments and Future Plans
Table 55. Haisco Pharmaceutical Company Information, Head Office, and Major Competitors
Table 56. Haisco Pharmaceutical Major Business
Table 57. Haisco Pharmaceutical Neurodegenerative Disease Product and Solutions
Table 58. Haisco Pharmaceutical Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Haisco Pharmaceutical Recent Developments and Future Plans
Table 60. Jingxin Pharmaceutical Company Information, Head Office, and Major Competitors
Table 61. Jingxin Pharmaceutical Major Business
Table 62. Jingxin Pharmaceutical Neurodegenerative Disease Product and Solutions
Table 63. Jingxin Pharmaceutical Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Jingxin Pharmaceutical Recent Developments and Future Plans
Table 65. Dongcheng Biochemicals Company Information, Head Office, and Major Competitors
Table 66. Dongcheng Biochemicals Major Business
Table 67. Dongcheng Biochemicals Neurodegenerative Disease Product and Solutions
Table 68. Dongcheng Biochemicals Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Dongcheng Biochemicals Recent Developments and Future Plans
Table 70. Hisun Pharmaceutical Company Information, Head Office, and Major Competitors
Table 71. Hisun Pharmaceutical Major Business
Table 72. Hisun Pharmaceutical Neurodegenerative Disease Product and Solutions
Table 73. Hisun Pharmaceutical Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Hisun Pharmaceutical Recent Developments and Future Plans
Table 75. Luye Pharma Company Information, Head Office, and Major Competitors
Table 76. Luye Pharma Major Business
Table 77. Luye Pharma Neurodegenerative Disease Product and Solutions
Table 78. Luye Pharma Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Luye Pharma Recent Developments and Future Plans
Table 80. Ark Pharmaceutical Company Information, Head Office, and Major Competitors
Table 81. Ark Pharmaceutical Major Business
Table 82. Ark Pharmaceutical Neurodegenerative Disease Product and Solutions
Table 83. Ark Pharmaceutical Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Ark Pharmaceutical Recent Developments and Future Plans
Table 85. Kanghong Pharmaceutical Company Information, Head Office, and Major Competitors
Table 86. Kanghong Pharmaceutical Major Business
Table 87. Kanghong Pharmaceutical Neurodegenerative Disease Product and Solutions
Table 88. Kanghong Pharmaceutical Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Kanghong Pharmaceutical Recent Developments and Future Plans
Table 90. Huahai Pharmaceutical Company Information, Head Office, and Major Competitors
Table 91. Huahai Pharmaceutical Major Business
Table 92. Huahai Pharmaceutical Neurodegenerative Disease Product and Solutions
Table 93. Huahai Pharmaceutical Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Huahai Pharmaceutical Recent Developments and Future Plans
Table 95. BORA PHARMACEUTICALS Company Information, Head Office, and Major Competitors
Table 96. BORA PHARMACEUTICALS Major Business
Table 97. BORA PHARMACEUTICALS Neurodegenerative Disease Product and Solutions
Table 98. BORA PHARMACEUTICALS Neurodegenerative Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. BORA PHARMACEUTICALS Recent Developments and Future Plans
Table 100. Global Neurodegenerative Disease Revenue (USD Million) by Players (2019-2024)
Table 101. Global Neurodegenerative Disease Revenue Share by Players (2019-2024)
Table 102. Breakdown of Neurodegenerative Disease by Company Type (Tier 1, Tier 2, and Tier 3)
Table 103. Market Position of Players in Neurodegenerative Disease, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 104. Head Office of Key Neurodegenerative Disease Players
Table 105. Neurodegenerative Disease Market: Company Product Type Footprint
Table 106. Neurodegenerative Disease Market: Company Product Application Footprint
Table 107. Neurodegenerative Disease New Market Entrants and Barriers to Market Entry
Table 108. Neurodegenerative Disease Mergers, Acquisition, Agreements, and Collaborations
Table 109. Global Neurodegenerative Disease Consumption Value (USD Million) by Type (2019-2024)
Table 110. Global Neurodegenerative Disease Consumption Value Share by Type (2019-2024)
Table 111. Global Neurodegenerative Disease Consumption Value Forecast by Type (2025-2030)
Table 112. Global Neurodegenerative Disease Consumption Value by Application (2019-2024)
Table 113. Global Neurodegenerative Disease Consumption Value Forecast by Application (2025-2030)
Table 114. North America Neurodegenerative Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 115. North America Neurodegenerative Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 116. North America Neurodegenerative Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 117. North America Neurodegenerative Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 118. North America Neurodegenerative Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 119. North America Neurodegenerative Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 120. Europe Neurodegenerative Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 121. Europe Neurodegenerative Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 122. Europe Neurodegenerative Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 123. Europe Neurodegenerative Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 124. Europe Neurodegenerative Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 125. Europe Neurodegenerative Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 126. Asia-Pacific Neurodegenerative Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 127. Asia-Pacific Neurodegenerative Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 128. Asia-Pacific Neurodegenerative Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 129. Asia-Pacific Neurodegenerative Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 130. Asia-Pacific Neurodegenerative Disease Consumption Value by Region (2019-2024) & (USD Million)
Table 131. Asia-Pacific Neurodegenerative Disease Consumption Value by Region (2025-2030) & (USD Million)
Table 132. South America Neurodegenerative Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 133. South America Neurodegenerative Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 134. South America Neurodegenerative Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 135. South America Neurodegenerative Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 136. South America Neurodegenerative Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 137. South America Neurodegenerative Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 138. Middle East & Africa Neurodegenerative Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 139. Middle East & Africa Neurodegenerative Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 140. Middle East & Africa Neurodegenerative Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 141. Middle East & Africa Neurodegenerative Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 142. Middle East & Africa Neurodegenerative Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 143. Middle East & Africa Neurodegenerative Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 144. Neurodegenerative Disease Raw Material
Table 145. Key Suppliers of Neurodegenerative Disease Raw Materials
LIST OF FIGURES
Figure 1. Neurodegenerative Disease Picture
Figure 2. Global Neurodegenerative Disease Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Neurodegenerative Disease Consumption Value Market Share by Type in 2023
Figure 4. NMDA
Figure 5. SSRIs
Figure 6. Dopamine Inhibitors
Figure 7. Global Neurodegenerative Disease Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Neurodegenerative Disease Consumption Value Market Share by Application in 2023
Figure 9. Parkinson’s Disease Picture
Figure 10. Huntington Disease Picture
Figure 11. Amyotrophic Lateral Sclerosis Picture
Figure 12. Alzheimer’s Disease Picture
Figure 13. Global Neurodegenerative Disease Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Neurodegenerative Disease Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Neurodegenerative Disease Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Neurodegenerative Disease Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Neurodegenerative Disease Consumption Value Market Share by Region in 2023
Figure 18. North America Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Neurodegenerative Disease Revenue Share by Players in 2023
Figure 24. Neurodegenerative Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Neurodegenerative Disease Market Share in 2023
Figure 26. Global Top 6 Players Neurodegenerative Disease Market Share in 2023
Figure 27. Global Neurodegenerative Disease Consumption Value Share by Type (2019-2024)
Figure 28. Global Neurodegenerative Disease Market Share Forecast by Type (2025-2030)
Figure 29. Global Neurodegenerative Disease Consumption Value Share by Application (2019-2024)
Figure 30. Global Neurodegenerative Disease Market Share Forecast by Application (2025-2030)
Figure 31. North America Neurodegenerative Disease Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Neurodegenerative Disease Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Neurodegenerative Disease Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Neurodegenerative Disease Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Neurodegenerative Disease Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Neurodegenerative Disease Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 41. France Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Neurodegenerative Disease Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Neurodegenerative Disease Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Neurodegenerative Disease Consumption Value Market Share by Region (2019-2030)
Figure 48. China Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 51. India Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Neurodegenerative Disease Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Neurodegenerative Disease Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Neurodegenerative Disease Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Neurodegenerative Disease Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Neurodegenerative Disease Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Neurodegenerative Disease Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 65. Neurodegenerative Disease Market Drivers
Figure 66. Neurodegenerative Disease Market Restraints
Figure 67. Neurodegenerative Disease Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Neurodegenerative Disease in 2023
Figure 70. Manufacturing Process Analysis of Neurodegenerative Disease
Figure 71. Neurodegenerative Disease Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Neurodegenerative Disease Picture
Figure 2. Global Neurodegenerative Disease Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Neurodegenerative Disease Consumption Value Market Share by Type in 2023
Figure 4. NMDA
Figure 5. SSRIs
Figure 6. Dopamine Inhibitors
Figure 7. Global Neurodegenerative Disease Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Neurodegenerative Disease Consumption Value Market Share by Application in 2023
Figure 9. Parkinson’s Disease Picture
Figure 10. Huntington Disease Picture
Figure 11. Amyotrophic Lateral Sclerosis Picture
Figure 12. Alzheimer’s Disease Picture
Figure 13. Global Neurodegenerative Disease Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Neurodegenerative Disease Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Neurodegenerative Disease Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Neurodegenerative Disease Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Neurodegenerative Disease Consumption Value Market Share by Region in 2023
Figure 18. North America Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Neurodegenerative Disease Revenue Share by Players in 2023
Figure 24. Neurodegenerative Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Neurodegenerative Disease Market Share in 2023
Figure 26. Global Top 6 Players Neurodegenerative Disease Market Share in 2023
Figure 27. Global Neurodegenerative Disease Consumption Value Share by Type (2019-2024)
Figure 28. Global Neurodegenerative Disease Market Share Forecast by Type (2025-2030)
Figure 29. Global Neurodegenerative Disease Consumption Value Share by Application (2019-2024)
Figure 30. Global Neurodegenerative Disease Market Share Forecast by Application (2025-2030)
Figure 31. North America Neurodegenerative Disease Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Neurodegenerative Disease Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Neurodegenerative Disease Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Neurodegenerative Disease Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Neurodegenerative Disease Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Neurodegenerative Disease Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 41. France Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Neurodegenerative Disease Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Neurodegenerative Disease Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Neurodegenerative Disease Consumption Value Market Share by Region (2019-2030)
Figure 48. China Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 51. India Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Neurodegenerative Disease Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Neurodegenerative Disease Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Neurodegenerative Disease Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Neurodegenerative Disease Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Neurodegenerative Disease Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Neurodegenerative Disease Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Neurodegenerative Disease Consumption Value (2019-2030) & (USD Million)
Figure 65. Neurodegenerative Disease Market Drivers
Figure 66. Neurodegenerative Disease Market Restraints
Figure 67. Neurodegenerative Disease Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Neurodegenerative Disease in 2023
Figure 70. Manufacturing Process Analysis of Neurodegenerative Disease
Figure 71. Neurodegenerative Disease Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
